KARACHI: The pharmaceutical sector continued on a growth trajectory during the first quarter of the fiscal year posting a 20 percent growth in sales, JS Global Capital noted in a report.
“Sales during the quarter depicted robust growth of 20 percent amid high demand for pharmaceutical products coupled with the impact of the latest price increases”.
Higher sales during the quarter also led to overall earnings growth, which increased by 58 percent in the period under review.
Various positives have played out favourably for the sector of late, including appreciating Pakistani rupee, relaxation of Covid-19 restrictions (leading to higher demand of OPD), price increases (particularly in hardship cases) and higher demand for pharmaceutical products amid a pandemic situation.